Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA approves Erbitux to treat late-stage head and neck cancer

The U.S. Food and Drug Administration today approved Erbitux ( cetuximab ) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.

REFINE

medications
- - Remove Erbitux filter (-) Remove Erbitux filter Erbitux
conditions
- - Remove Cancer filter (-) Remove Cancer filter Cancer
    Remove Thyroid Cancer filter (-) Remove Thyroid Cancer filter Thyroid Cancer
    
    Apply Esophageal Cancer filter Esophageal Cancer (1) Apply Esophageal Cancer filter
    
    Apply Nasal Cancer filter Nasal Cancer (1) Apply Nasal Cancer filter
    
    Apply Oral Cancer filter Oral Cancer (1) Apply Oral Cancer filter